Recombinant Human Melanocortin-2 receptor accessory protein 2 (MRAP2)

What is MRAP2 and how does it relate to MRAP1?

MRAP2 is a homologue of MRAP1 (originally identified as essential for ACTH receptor/melanocortin 2 receptor function). Both are single-pass transmembrane domain proteins that can form antiparallel homodimers. While MRAP1 is essential for MC2R trafficking and function, MRAP2 has broader regulatory effects across multiple receptors. MRAP2, like MRAP1, is glycosylated at the N-terminus, and this post-translational modification appears to be functionally important .

To study the relationship between MRAP1 and MRAP2:

• Compare tissue expression patterns using RT-PCR across multiple tissues

• Analyze protein sequence homology using alignment tools

• Conduct comparative co-immunoprecipitation studies with various receptors

• Perform mutagenesis studies targeting conserved domains

What is the tissue distribution pattern of MRAP2?

MRAP2 has a distinct tissue expression pattern from MRAP1, with principal expression in the brain and adrenal gland . Research shows MRAP2 is also expressed in human metabolic tissues including pancreatic islets, gut, kidney, adipose tissue, and skeletal muscle .

For accurate tissue distribution analysis:

• Use quantitative RT-PCR with intron-spanning primers to avoid genomic DNA amplification

• Validate expression using Western blot with specific antibodies

• Employ immunohistochemistry to identify specific cell types expressing MRAP2

• Consider single-cell RNA sequencing for detailed cellular distribution

What is the structural topology of MRAP2?

MRAP2 adopts a unique dual-topology homodimeric structure that is resistant to SDS, reducing agents, and heat. Western blotting reveals an approximately 48-kDa band in adrenal gland and brain tissue, consistent with an MRAP2 dimeric structure in vivo . This antiparallel orientation appears critical for function .

Methodological approaches to study MRAP2 topology:

• Use epitope tagging at both N- and C-termini (e.g., FLAG, MYC tags)

• Apply live-cell immunofluorescence staining to determine membrane orientation

• Employ crosslinking studies with dithiobis (succinimidyl propionate)

• Use glycosylation site mapping to confirm N-terminal orientation

How does MRAP2 interact with melanocortin receptors?

MRAP2 interacts with all five melanocortin receptors (MC1R-MC5R) as demonstrated by co-immunoprecipitation studies . For MC2R, MRAP2 facilitates trafficking to the cell surface but requires significantly higher ACTH concentrations for signaling compared to MRAP1 . For MC1R, MC3R, MC4R, and MC5R, MRAP2 can reduce receptor responsiveness to [Nle4,D-Phe7]alpha-melanocyte-stimulating hormone (NDP-MSH) .

To study these interactions:

• Perform co-immunoprecipitation with HA-tagged MCRs and FLAG- or MYC-tagged MRAP2

• Use cell-surface expression assays to quantify receptor trafficking

• Measure cAMP generation to assess functional effects

• Employ BRET/FRET assays to measure direct protein-protein interactions

What is the molecular mechanism by which MRAP2 regulates MC4R function?

MRAP2 is critical for the weight-regulating function of MC4R neurons and the ciliary localization of MC4R. Targeting of MC4R to neuronal primary cilia is essential for the control of long-term energy homeostasis . Recent modeling suggests MRAP2 may interact with melanocortin receptors at TM5-TM6 regions, which are important for receptor activation and G protein coupling .

Experimental approaches:

• Use immunofluorescence microscopy to track ciliary localization of MC4R

• Compare wild-type and mutant MC4R trafficking in the presence/absence of MRAP2

• Employ cell-specific knockout models (e.g., MC4R neuron-specific MRAP2 deletion)

• Utilize ligand binding assays to assess receptor affinity changes

What experimental systems are optimal for studying MRAP2-receptor interactions?

Different experimental systems have yielded contradictory results regarding MRAP2 function. For example, some studies showed MRAP2 enables MC2R response to ACTH while others found the receptor unresponsive . This variability highlights the importance of selecting appropriate experimental systems.

Recommended approaches:

• Compare multiple cell lines (HEK293, CHO, Y1 adrenal cells)

• Use neuronal cell lines for MC4R studies due to its CNS expression

• Consider primary neuronal cultures for physiologically relevant conditions

• Employ tissue-specific expression systems rather than only heterologous expression

• Validate findings across multiple experimental platforms

How can researchers accurately measure MRAP2's effects on receptor trafficking versus signaling?

MRAP2 has distinct effects on receptor trafficking and signaling that must be separately evaluated. For instance, N9Q-FLAG mutant MRAP2 assists MC2R trafficking to the cell surface but fails to enable receptor signaling .

Methodological separation:

• Use cell-surface labeling techniques (biotinylation, fluorescent antibodies)

• Implement confocal microscopy with fluorescently tagged receptors

• Measure receptor signaling via multiple pathways (G protein activation, cAMP production)

• Employ bioluminescence resonance energy transfer (BRET) to monitor receptor-effector coupling

How can researchers effectively analyze the impact of MRAP2 mutations on receptor function?

To investigate MRAP2 structure-function relationships, researchers have created variant conformations by inverting or transposing domains. These variants showed proper formation of antiparallel homodimers and binding to MC4R but altered regulatory effects on receptor function .

Recommended mutation analysis approach:

• Construct systematic mutations targeting key domains (N-terminal, transmembrane, C-terminal)

• Characterize both structural impacts (dimerization, receptor binding) and functional effects

• Employ dose-response curves to assess changes in potency and efficacy

• Compare effects across multiple receptor types

What approaches best model MRAP2's role in energy homeostasis?

MRAP2 plays a crucial role in energy homeostasis, with different phenotypes observed between global and MC4R neuron-specific Mrap2 deletion in mice. Global deletion causes late-onset hyperphagia and obesity, while MC4R neuron-specific deletion leads to early-onset hyperphagia and obesity .

Recommended experimental models:

• Compare tissue-specific knockout models (global vs. neuron-specific)

• Utilize CRISPR/Cas9 technology for precise genetic manipulation

• Implement metabolic phenotyping (food intake, energy expenditure, glucose tolerance)

• Measure hormone levels associated with metabolism (leptin, ghrelin, insulin)

How do loss-of-function mutations in MRAP2 contribute to human obesity?

Loss-of-function mutations in MRAP2 are associated with hyperphagic obesity in humans, with a phenotype that includes hyperglycemia and hypertension. This differs from MC4R deficiency, suggesting MRAP2 has broader roles beyond MC4R regulation .

Research methodology:

• Perform genetic screening in obesity cohorts

• Characterize functional impacts of identified mutations

• Compare phenotypic data between MRAP2 and MC4R mutation carriers

• Implement genotype-phenotype correlation studies

How does MRAP2 interact with non-melanocortin receptors?

MRAP2 interacts with receptors beyond the melanocortin family, including prokineticin receptors and the growth hormone secretagogue receptor 1a (GHSR1a), the ghrelin receptor . This may explain the broader metabolic phenotypes observed in MRAP2-deficient models.

Experimental approaches:

• Use BRET assays to measure direct interaction with various GPCRs

• Implement cross-linking studies to verify physical association

• Assess functional impacts through signaling assays (G protein activation, β-arrestin recruitment)

• Perform domain mapping to identify interaction interfaces

What methodologies best characterize MRAP2's regulation of β-arrestin recruitment?

MRAP2 inhibits β-arrestin-2 recruitment to Prokineticin Receptor 2 (PKR2). This effect appears dependent on the C-terminal region of PKR2, as demonstrated by experiments with PKR2-ΔC52 mutant receptors .

Recommended experimental design:

• Implement BRET assays with luminescent receptors and GFP-tagged β-arrestin-2

• Perform concentration-response curves with various receptor:MRAP2 ratios

• Compare wild-type receptors with C-terminal truncation mutants

• Measure downstream signaling consequences (ERK phosphorylation, receptor internalization)

For optimal results, researchers should conduct concentration-dependent experiments, as shown in Figure 2 of reference , where increasing MRAP2:receptor ratios (1:5, 1:15) demonstrated progressive inhibition of β-arrestin-2 recruitment.

How can contradictory findings regarding MRAP2's role in MC2R signaling be reconciled?

Studies have reported contradictory findings about MRAP2's ability to enable MC2R response to ACTH. Some showed functionality while others reported unresponsiveness . The resolution appears to be dose-dependent, with MRAP2-associated MC2R requiring 1000-fold higher ACTH concentrations compared to MRAP1-associated MC2R.

Research strategy to resolve contradictions:

• Implement wide-range dose-response curves (10^-12 to 10^-6 M ACTH)

• Standardize expression systems and quantify receptor:accessory protein ratios

• Consider physiological ACTH concentrations in experimental design

• Test combinatorial effects of MRAP1 and MRAP2 co-expression

What are the emerging techniques for studying MRAP2 structure and function?

Recent advances include AI-based structural modeling of MRAP2-receptor complexes, suggesting that MRAP2 may interact with TM5-TM6 regions of melanocortin receptors . These regions are known to be critical for receptor activation and G protein coupling.

Cutting-edge methodological approaches:

• Implement cryo-electron microscopy to resolve MRAP2-receptor complexes

• Use molecular dynamics simulations to model interaction dynamics

• Apply AlphaFold or similar AI tools for structure prediction

• Develop nanobody-based probes for conformational studies

By employing these advanced approaches, researchers can continue to unravel the complex roles of MRAP2 in receptor regulation and energy homeostasis, potentially leading to novel therapeutic targets for metabolic disorders.